Single-dose T3 administration: kinetics and effects on biochemical and physiological parameters

Prior research has shown that liothyronine administration affects thyroid hormone levels and heart rate within hours. However, no prior work had resolved the full duration of these effects beyond 24 hours. Established knowledge includes the rapid metabolism of triiodothyronine and its influence on heart rate. That uncertainty drove the need to extend monitoring past the typical 24-hour window. No prior study had tracked TSH suppression beyond 96 hours after a single dose. This gap motivated the investigation of both short- and long-term effects. The study aimed to clarify how long TSH suppression lasts compared to the transient rise in triiodothyronine. The findings may suggest new insights into dosing strategies for thyroid hormone therapy.

The aim of this study was to evaluate the kinetics and effects of a single liothyronine dose over an extended period. The specific problem was to determine how long TSH suppression lasts compared to the transient rise in triiodothyronine. The motivation stemmed from the lack of data on effects beyond 24 hours. The researchers propose that a single dose may have prolonged effects on TSH. This approach allows for a better understanding of the drug's pharmacodynamics. The study focused on healthy participants to avoid confounding variables. The design enabled tracking of both biochemical and physiological responses. The results may suggest implications for clinical dosing and monitoring schedules.

The study involved 12 healthy euthyroid participants who received a single 50-mcg dose of liothyronine. Blood samples were collected over four days to assess thyroid hormone levels. Vital signs were monitored to track physiological changes. Total and free triiodothyronine concentrations were measured at multiple time points. Free and total thyroxine levels were also assessed for comparison. TSH levels were analyzed to determine suppression patterns. Heart rate was recorded to evaluate cardiovascular effects. The study design allowed for tracking both short- and long-term responses.

Triiodothyronine concentrations peaked at 2.5 hours after administration. Heart rate increased significantly by 5 hours and remained elevated. TSH suppression began at 2 hours and reached a nadir at 12 hours. The lowest TSH value was significantly lower than baseline (P < 0.001). TSH remained suppressed for 2-3 days after the initial dose. The increase in triiodothyronine was followed by a transient rise in heart rate. The heart rate elevation was short-lived but distinct from TSH suppression. The study found a clear lag between hormone levels and physiological effects.

The authors propose that a single dose of liothyronine produces both short- and long-term effects. The study found that TSH suppression lasted longer than the rise in triiodothyronine. The increase in heart rate was transient but followed the hormone peak. The lag time between hormone levels and effects on the heart and pituitary was distinct. The findings suggest that TSH suppression is more sustained than the initial hormone surge. The results may suggest that dosing strategies should consider prolonged TSH effects. The study highlights the importance of monitoring beyond 24 hours. The authors propose that these findings may inform future clinical approaches.